Entera Bio
ENTX

Entera Bio (ENTX) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$9.00 from $10.00Apr 27, 2026
HC Wainwright & Co.MaintainedBuy$10.00Feb 9, 2026
HC Wainwright & Co.MaintainedBuy$10.00Mar 18, 2025
HC Wainwright & Co.MaintainedBuy$10.00Nov 11, 2024
HC Wainwright & Co.MaintainedBuy$10.00Oct 7, 2024
HC Wainwright & Co.MaintainedBuy$10.00Sep 27, 2024
HC Wainwright & Co.MaintainedBuy$10.00Aug 12, 2024
HC Wainwright & Co.MaintainedBuy$10.00Jun 5, 2024
HC Wainwright & Co.MaintainedBuy$10.00May 14, 2024
HC Wainwright & Co.MaintainedBuy$10.00May 13, 2024
HC Wainwright & Co.MaintainedBuy$10.00Apr 2, 2024
HC Wainwright & Co.MaintainedBuy$10.00Dec 11, 2023
HC Wainwright & Co.MaintainedBuy$10.00Sep 13, 2023
HC Wainwright & Co.MaintainedBuy$10.00Sep 11, 2023
HC Wainwright & Co.MaintainedBuy$10.00May 8, 2023
HC Wainwright & Co.MaintainedBuy$10.00Apr 4, 2023

Frequently asked questions

  • What is the latest analyst rating on ENTX?

    On Apr 27, 2026, HC Wainwright & Co. maintained Entera Bio at Buy with a price target of $9.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.